India Inc.’s Credit Health At Decadal Best, Say Rating Agencies
India Inc.'s credit health is at its best in a decade on improving demand, government's relief measures and deleveraging efforts by companies.
Corporate credit profile has posted its strongest performance in FY22, according to India Ratings & Research. The share of downgrades to upgrades, it said, is at a decadal low of 0.3 compared with 1.4 in FY21.
“This marks a reversal of the past three years' trend, where downgrades exceeded upgrades. During the year, Ind-Ra upgraded the ratings of 276 issuers, representing 23% of the rated portfolio. Ratings downgrades were significantly lower, seen in only 86 issuers,” it said in a report.
Positive rating actions were seen across almost all sectors in FY22, indicating a broader economic recovery, Suparna Banerji, associate director at Ind-Ra, said. “This is in contrast to FY21 where upgrades were limited to a few sectors. A high number of upgrades were seen in sectors such as chemicals due to the push for import substitution and increasing export opportunities (China+1 strategy). Pharmaceuticals benefitted from continued growth momentum, a strong performance in India business and cost optimisation. Metals and mining was supported by strong realisations and a robust demand from end-user sectors.”
For Crisil and CareEdge, too, credit ratios improved.
Crisil's credit ratio rose to 5.04 times in the second half compared with 2.96 times in the first half. In all, there were 569 upgrades and 113 downgrades in the second half.
“The performance comes on the back of a sustained improvement in demand that lifted the revenue of most sectors to their pre-pandemic levels, secular deleveraging by debt issuers, seen over the past few fiscals and through the pandemic, and proactive relief measures by the government that cushioned the pandemic blow,” it said.
According to CareEdge Ratings, it has clocked a decadal high credit ratio at 2.64 times in the second half, pointing toward a “positive” outlook. “The uptrend was contributed by upgrades in both infrastructure and manufacturing/services sectors.” The agency upgraded ratings of 468 entities and downgraded 177.
Credit ratio for the banking and financial services segment, it said, moved above one for the first time since the IL&FS-fueled liquidity crisis.
Crisil Ratings said its outlook on credit quality remains “positive” even as it expects some moderation in the credit ratio. “Persistent inflationary trends can affect both, consumption demand and profitability of firms, which can temper corporate credit quality. Any new Covid-19 variant that dilutes the benefit of vaccination also remains a risk to our credit quality outlook. Nevertheless, deleveraged balance sheets structurally position India Inc. well to navigate these uncertain times,” Somasekhar Vemuri, senior director at Crisil, said.
Note: Crisil and CareEdge calculate credit ratio as the share of upgrades to downgrades. That implies a ratio higher than one denotes positive quality.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.